Source: Trials in Vaccinology. Unidade: FM
Subjects: ANESTÉSICOS, HIIV, IMUNOLOGIA, EPITOPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Susan Pereira et al. Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine. Trials in Vaccinology, v. 3, p. 95-101, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.trivac.2014.05.001. Acesso em: 29 maio 2024.APA
Ribeiro, S. P., Apostólico, J. de S., Almeida, R. R., Kalil, J., & Cunha-Neto, E. (2014). Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine. Trials in Vaccinology, 3, 95-101. doi:10.1016/j.trivac.2014.05.001NLM
Ribeiro SP, Apostólico J de S, Almeida RR, Kalil J, Cunha-Neto E. Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine [Internet]. Trials in Vaccinology. 2014 ; 3 95-101.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.trivac.2014.05.001Vancouver
Ribeiro SP, Apostólico J de S, Almeida RR, Kalil J, Cunha-Neto E. Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine [Internet]. Trials in Vaccinology. 2014 ; 3 95-101.[citado 2024 maio 29 ] Available from: https://doi.org/10.1016/j.trivac.2014.05.001
